The co-transduction of Nurr1 and Brn4 genes induces the differentiation of neural stem cells into dopaminergic neurons

Cell Biology International

Volumn 35, Issue 12, 2011, Pages 1217-1223

  Tan, Xue Feng ^a,b   Jin, Guo Hua ^a   Tian, Mei Ling ^a   Qin, Jian Bing ^a   Zhang, Lei ^a   Zhu, Hui Xia ^a   Li, Hao Ming ^a  

^a NANTONG UNIVERSITY   (China)

^b SOOCHOW UNIVERSITY   (China)

Author keywords

Brn 4; Differentiation; Dopaminergic neuron; Neural stem cells; Nuclear receptor related factor 1 (Nurr1); Parkinson's disease

Indexed keywords

DOPAMINE; DOPAMINE TRANSPORTER; ENHANCED GREEN FLUORESCENT PROTEIN; NUCLEAR RECEPTOR RELATED FACTOR 1; RNA; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ARTICLE; BRN4 GENE; CELL DIFFERENTIATION; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; GENE; GENE EXPRESSION; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MESENCEPHALON; NEURAL STEM CELL; NEURITE; NONHUMAN; NURR1 GENE; PHENOTYPE; PROTEIN DOMAIN; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; WESTERN BLOTTING;

ANIMALS; CELL DIFFERENTIATION; DOPAMINERGIC NEURONS; MESENCEPHALON; NERVE TISSUE PROTEINS; NEURAL STEM CELLS; NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 2; POU DOMAIN FACTORS; RATS; RATS, SPRAGUE-DAWLEY; TRANSDUCTION, GENETIC;

EID: 80955159715     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1042/CBI20110028     Document Type: Article

References (41)

1. Alavian KN, Scholz C, Simon HH. Transcriptional regulation of mesencephalic dopaminergic neurons: the full circle of life and death. Mov Disord 2008;23:319-28.
2. Andersen B, Rosenfeld MG. POU domain factors in the neuroendocrine system: lessons from developmental biology provide insights into human disease. Endocr Rev 2001;22:3-35.
3. Ang SL. Transcriptional control of midbrain dopaminergic neuron development. Development 2006;133:3499-506.
4. Berwick DC, Calissano M, Corness JD, Cool SJ, Latchman DS. Regulation of Brn-3a N-terminal transcriptional activity by MEK1/2-ERK1/2 signalling in neural differentiation. Brain Res 2009;1256:8-18.
5. Borlongan CV, Sanberg PR. Neural transplantation for treatment of Parkinson's disease. Drug Discov Today 2002;7:674-82.
6. Castro DS, Skowronska-Krawczyk D, Armant O, Donaldson IJ, Parras C, Hunt C et al. Proneural bHLH and Brn proteins coregulate a neurogenic program through cooperative binding to a conserved DNA motif. Dev Cell 2006;11:831-44.
7. Deierborg T, Soulet D, Roybon L, Hall V, Brundin P. Emerging restorative treatments for Parkinson's desease. Prog Neurobiol 2008;85:407-32.
8. Doetsch F. The glial identity of neural stem cells. Nat Neurosci 2003;6:1127-34.
9. Friling S, Andersson E, Thompson LH, Jönsson ME, Hebsgaard JB, Nanou E et al. Efficient production of mesencephalic dopamine neurons by Lmx1a expression in embryonic stem cells. Proc Natl Acad Sci USA 2009;106:7613-18.
10. Hermanson E, Joseph B, Castro D, Lindqvist E, Aarnisalo P, Wallén A et al. Nurr1 regulates dopamine synthesis and storage in MN9D dopamine cells. Exp Cell Res 2003;288:324-34.
11. Hobert O, Westphal H. Functions of LIM-homeobox genes. Trends Genet 2000;16:75-83.
12. Jin Z, Liu L, Bian W, Chen Y, Xu G, Cheng L et al. Different transcription factors regulate nestin gene expression during P19 cell neural differentiation and central nervous system development. J Biol Chem 2009;284:8160-73.
13. Josephson R, Muller T, Pickel J, Okabe S, Reynolds K, Turner PA et al. POU transcription factors control expression of CNS stem cellspecific genes. Development 1998;125:3087-100.
14. Kim JY, Koh HC, Lee JY, Chang MY, Kim YC, Chung HY et al. Dopaminergic neuronal differentiation from rat embryonic neural precursors by Nurr1 overexpression. J Neurochem 2003;85:1443-54.
15. Kim HJ, Sugimori M, Nakafuku M, Svendsen CN. Control of neurogenesis and tyrosine hydroxylase expression in neural progenitor cells through bHLH proteins and Nurr1. Exp Neurol 2007;203:394-405.
16. Kim KS, Kim CH, Hwang DY, Seo H, Chung S, Hong SJ et al. Orphan nuclear receptor Nurr1 directly transactivates the promoter activity of the tyrosine hydroxylase gene in a cell-specific manner. J Neurochem 2003;85:622-34.
17. Lee HS, Bae EJ, Yi SH, Shim JW, Jo AY, Kang JS et al. Foxa2 and Nurr1 synergistically yield A9 nigral dopamine neurons exhibiting improved differentiation, function and cell survival. Stem Cells 2010;28:501-12.
18. Lindvall O, Björklund A. Cell therapy in Parkinson's disease. NeuroRx 2004;1:382-93.
19. Lindvall O, Kokaia Z. Stem cells in human neurodegenerative disorderstime for clinical translation? J Clin Invest 2010;120:29-40.
20. Maherali N, Sridharan R, Xie W, Utikal J, Eminli S, Arnold K et al. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 2007;1:55-70.
21. Martinat C, Bacci JJ, Leete T, Kim J, Vanti WB, Newman AH et al. Cooperative transcription activation by Nurr1 and Pitx3 induces embryonic stem cell maturation to the midbrain dopamine neuron phenotype. Proc Natl Acad Sci USA 2006;103:2874-9.
22. Miyagi S, Nishimoto M, Saito T, Ninomiya M, Sawamoto K, Okano H et al. The Sox2 regulatory region 2 functions as a neural stem cell specific enhancer in the telencephalon. J Biol Chem 2006;281:13374-81.
23. Morizane A, Li JY, Brundin P. From bench to bed: the potential of stem cells for the treatment of Parkinson's disease. Cell Tissue Res 2008;331:323-36.
24. Nat R, Nilbratt M, Narkilahti S, Winblad B, Hovatta O, Nordberg A. Neurogenic neuroepithelial and radial glial cells generated from six human embryonic stem cell lines in serum-free suspension and adherent cultures. Glia 2007;55:385-99.
25. Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells Nature 2007;448:313-7.
26. Park CH, Kang JS, Kim JS, Chung S, Koh JY, Yoon EH et al. Differential actions of the proneural genes encoding Mash1 and neurogenins in Nurr1-induced dopamine neuron differentiation. J Cell Sci 2006a;119:2310-20.
27. Park CH, Kang JS, Shin YH, Chang MY, Chung S, Koh HC et al. Acquisition of in vitro and in vivo functionality of Nurr1-induced dopamine neurons. FASEB J 2006b;20:2553-5.
28. Pfaffl MW. A new mathematical model for relative quantification in realtime RT-PCR. Nucleic Acids Res 2001;29:2002-7.
29. Prakash N, Wurst W. Genetic networks controlling the development of midbrain dopaminergic neurons. J Physiol 2006;575:403-10.
30. Samii A, Nutt JG, Ransom BR. Parkinson's disease. Lancet 2004;363:1783-93.
31. Sakurada K, Ohshima-Sakurada M, Palmer TD, Gage FH. Nurr1, an orphan nuclear receptor, is a transcriptional activator of endogenous tyrosine hydroxylase in neural progenitor cells derived from the adult brain. Development 1999;126:4017-26.
32. Saucedo-Cardenas O, Quintana-Hau JD, Le WD, Smidt MP, Cox JJ, DeMayo F et al. Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons. Proc Natl Acad Sci USA 1998;95:4013-8.
33. Shim JW, Park CH, Bae YC, Bae JY, Chung S, Chang MY et al. Generation of functional dopamine neurons from neural precursor cells isolated from the subventricular zone and white matter of the adult rat brain using Nurr1 overexpression. Stem Cells 2007;25:1252-62.
34. Smits SM, Ponnio T, Conneely OM, Burbach JP, Smidt MP. Involvement of Nurr1 in specifying the neurotransmitter identity of ventral midbrain dopaminergic neurons. Eur J Neurosci 2003;18:1731-8.
35. Snyder BJ, Olanow CW. Stem cell treatment for Parkinson's disease: an update for 2005. Curr Opin Neurol 2005;18:376-85.
36. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663-76.
37. Tan XF, Qin JB, Jin GH, Tian ML, Li HM, Zhu HX et al. Effects of Brn-4 on the neuronal differentiation of neural stem cells derived from rat midbrain. Cell Biol Int 2010;34:877-82.
38. Tanaka S, Kamachi Y, Tanouchi A, Hamada H, Jing N, Kondoh H. Interplay of SOX and POU factors in regulation of the Nestin gene in neural primordial cells. Mol Cell Biol 2004;24:8834-46.
39. Tran KD, Ho A, Jandial R. Stem cell transplantation methods. Adv Exp Med Biol 2010;671:41-57.
40. Wallén A, Perlmann T. Transcriptional control of dopamine neuron development. Ann NY Acad Sci 2003;991:48-60.
41. Wernig M, Meissner A, Foreman R, Brambrink T, Ku M, Hochedlinger K et al. In vitro reprogramming of fibroblasts into a pluripotent EScell-like state. Nature 2007;448:318-24.